Is Decision Diagnostics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Decision Diagnostics Corp (DECN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Decision Diagnostics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Decision Diagnostics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Decision Diagnostics Corp?

Muslim investors may consider investing in Decision Diagnostics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Decision Diagnostics Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Decision Diagnostics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Decision Diagnostics Corp updated?

The Shariah compliance status of Decision Diagnostics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Decision Diagnostics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Decision Diagnostics Corp?

You can check the latest Shariah compliance status of Decision Diagnostics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Decision Diagnostics Corp. Stock Analysis DECN

United States Health Care Nano Cap

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The firm is specialized in prescription, non-prescription diagnostics and home testing products. The company is a provider of prescription drugs, home testing products for the chronically ill, a fulfillment provider of direct to patient diabetes programs, and a developer of cell phone centric, e-health products and technology. Through its subsidiary, PharmaTech Solutions, Inc., the Company provides blood glucose home testing devices like GenUltimate! and PetSure! test strips and GenUltimate!4Pets monitoring system. The company also provides smart phone based electronic medical record (EMR) applications to be used by physicians at the point of care. These mobile applications allow physicians to access and update their patients' histories, medication data and care guidelines. The firm develops products that offer solutions to medical care professionals and management by providing physicians with essential information.

Financial Metrics & Statements of Decision Diagnostics Corp (DECN)

FAQ's for Decision Diagnostics Corp (DECN)

According to Musaffa’s Shariah screening methodology, Decision Diagnostics Corp (DECN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.